Go backIncome
Assets
Equity
Liabilities
Other
Societatea cu Răspundere Limitată CES PHARM
CES PHARM
is not in process of liquidation on Apr 30, 2024
To view all financial indicators, unlock this company.
Income
Financial indicator20202019
Net sales
157K MDL
-81%
817K MDL
-87%
Cost of goods sold
░░░░░░░░
-
Gross profit
░░░░░░░░
-
Distribution expenses
░░░░░░░░
-
Administrative expenses
░░░░░░░░
-
Other operating expenses
░░░░░░░░
-
Operating profit
░░░░░░░░
0%
░░░░░░░░
0%
Profit before tax
░░░░░░░░
0%
░░░░░░░░
0%
Net profit
-111K MDL
54%
-242K MDL
-154%
Assets
Financial indicator20202019
Total assets
1.30M MDL
1%
1.28M MDL
-43%
Current assets
░░░░░░░░
0%
░░░░░░░░
0%
Non-current assets
-
░░░░░░░░
0%
Equity
Financial indicator20202019
Equity
░░░░░░░░
0%
░░░░░░░░
0%
Share capital
░░░░░░░░
-
Profit and loss reserves
░░░░░░░░
-
Liabilities
Financial indicator20202019
Total liabilities
-
-
Short-term liabilities
░░░░░░░░
0%
░░░░░░░░
0%
Long-term liabilities
░░░░░░░░
0%
░░░░░░░░
0%
Other
Financial indicator20202019
Employees
-
2
0%
Your trusted source for business data
Socials
English, USA
English, USA